The journal Stem Cells Translational Medicine has a long track record of publishing great work. I also have a lot of respect for the editors there and I’ve published there myself. But a few recent events have sparked concerns including over possible undisclosed conflicts of interest in some papers there about cord blood for autism. […]
Cord conflicts at the journal Stem Cells Translational Medicine Read More »
This was a busy week for me working on a grant due Friday and a bunch of other stuff including happily analyzing a bunch of data, but there were tons of interesting papers recently including on pluripotency. California stem cell clinic court case on in the background Along the way this week I was occasionally
Weekly reads: court case, cancer stem cells, skin, pluripotency, & more Read More »
Mere weeks into the COVID pandemic, stunning graphics began to appear depicting the path of devastation of SARS-CoV-2 through a human lung. It’s only recently that we’ve come to understand what, exactly, is happening on a cellular level. The new view is thanks to single-cell RNA-sequencing, which analyzes the abundance of messenger RNAs in individual
COVID Traps Alveoli Cells in a Curious Progenitor State, Squelching Lung Regeneration Read More »
Does it make any sense medically or scientifically to use stem cell therapy for pain or neuropathy? There isn’t much solid evidence that this is a good way to go. However, there’s a vast scope of research ongoing in this area. Stem cell clinics have been earning millions of dollars selling this idea too. The
Fact-check of stem cell therapy for pain & neuropathy Read More »
I got some great entries for our The Niche stem cell picture contest. While I expected many bright colorful images, every year some of the pictures surprise me in certain ways. There was another surprise in that two entrants in the contest, both Assistant Professors, are sisters. A talented family! You can see the previous
The Niche stem cell picture contest winners: gut & astrocytes Read More »
Stem cell clinics violating federal regulations have been a major problem for the FDA. Next month the FDA faces a historic moment on this problem. A grace period for clinics to become FDA compliant ends in May. Even so, it appears that hundreds of clinics will remain non-compliant after that. Some of the worst clinics
I’m going to start off today’s recommended reads post with some stem cells for vision developments. I had some fun the last 2 weeks as people sent in their entries for our $100 stem cell picture contest. I’ll announce the winner this week. It’s going to be hard to choose given the great entries. Stem
Weekly reads: Stem cells for vision loss & recommended pubs Read More »
Can you really make living robots from stem cells called xenobots? How would this work? You take frog stem cells, supercomputers to tell you what to do with them, and you get xenobots? Well, kind of yes and no at this point. It’s a fascinating area. What are xenobots? What does the name “xenobot” bring
Xenobots: can you really make living robots from stem cells? Read More »
If you were to see the phrase ‘Advanced Therapy Medicinal Product’ (ATMP) you might guess, ‘an advanced treatment that is a medicine?’ but you will not get much more from this without doing a lot more homework. What is an ‘Advanced Therapy Medicinal Product’ or ATMP? Whoever decided that cell and gene therapy products should
Cell and gene therapy products: what is an ATMP? Read More »
It’s been a week with a wide variety of regenerative medicine papers and stem cell news. Here’s my earlier take from a few days ago on the Belmonte-led human-monkey chimeric embryo paper in Cell that broke this week. A few days ago I also put up a new video on our Stem Cell YouTube Channel